11 results
6-K
EX-99.1
ARGX
Argen X SE
21 Mar 24
Current report (foreign)
6:07am
the ADCC-mediated cell-killing potential of antibodies by 10- to 1000-fold. Cusatuzumab and ARGX-111 utilize POTELLIGENT® (source: Expert Opin Biol Ther
424B5
szs40ypjjlb4r0g
8 Nov 19
Prospectus supplement for primary offering
5:14pm
424B5
7jx95
6 Nov 19
Prospectus supplement for primary offering
5:26pm
424B5
tj8o6u3ladmqogtpl
20 Sep 18
Prospectus supplement for primary offering
8:04am
20-F
prntz23fl 37svfuoo4
26 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next